38 related articles for article (PubMed ID: 12188263)
1. Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).
Cyran CC; Sennino B; Fu Y; Rogut V; Shames DM; Chaopathomkul B; Wendland MF; McDonald DM; Brasch RC; Raatschen HJ
Eur J Radiol; 2012 May; 81(5):891-6. PubMed ID: 21889860
[TBL] [Abstract][Full Text] [Related]
2. Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.
Budde MD; Gold E; Jordan EK; Smith-Brown M; Frank JA
NMR Biomed; 2012 May; 25(5):726-36. PubMed ID: 21954124
[TBL] [Abstract][Full Text] [Related]
3. Application of Dynamic Contrast Enhanced Magnetic Resonance Imaging to Evaluate Angiogenic Response and Vascular Permeability.
Wallingford MC; Tarui T; Jayaraman N; Huggins GS; Dighe MK
Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1507-1509. PubMed ID: 31339781
[No Abstract] [Full Text] [Related]
4. Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging.
Kiessling F; Jugold M; Woenne EC; Brix G
Eur Radiol; 2007 Aug; 17(8):2136-48. PubMed ID: 17308924
[TBL] [Abstract][Full Text] [Related]
5. Assessing perfusion and capillary permeability changes induced by a VEGF inhibitor in human tumor xenografts using macromolecular MR imaging contrast media.
Clément O; Pradel C; Siauve N; Frouin F; Bruneteau G; Kahn E; Frija G; Cuénod CA
Acad Radiol; 2002 Aug; 9 Suppl 2():S328-9. PubMed ID: 12188264
[No Abstract] [Full Text] [Related]
6. Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weights.
Roberts TP; Turetschek K; Preda A; Novikov V; Moeglich M; Shames DM; Brasch RC; Weinmann HJ
Acad Radiol; 2002 Aug; 9 Suppl 2():S511-3. PubMed ID: 12188324
[No Abstract] [Full Text] [Related]
7. Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor.
Gossmann A; Helbich TH; Mesiano S; Shames DM; Wendland MF; Roberts TP; Ferrara N; Jaffe RB; Brasch RC
Am J Obstet Gynecol; 2000 Oct; 183(4):956-63. PubMed ID: 11035346
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme.
Gossmann A; Helbich TH; Kuriyama N; Ostrowitzki S; Roberts TP; Shames DM; van Bruggen N; Wendland MF; Israel MA; Brasch RC
J Magn Reson Imaging; 2002 Mar; 15(3):233-40. PubMed ID: 11891967
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograft.
Stefanik DF; Fellows WK; Rizkalla LR; Rizkalla WM; Stefanik PP; Deleo AB; Welch WC
J Neurooncol; 2001 Nov; 55(2):91-100. PubMed ID: 11817706
[TBL] [Abstract][Full Text] [Related]
10. Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?
Brasch RC; Gossmann A; Helbich TH; Kuriyama N; Roberts TP; Shames DM; van Bruggen N; Wendland MF; Israel MA
Acad Radiol; 2002 Aug; 9 Suppl 2():S326-7. PubMed ID: 12188263
[No Abstract] [Full Text] [Related]
11. Regulation of angiogenesis in malignant gliomas.
Guerin C; Laterra J
EXS; 1997; 79():47-64. PubMed ID: 9002220
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in human gliomas: prognostic and therapeutic implications.
Johnson JP; Bruce JN
EXS; 1997; 79():29-46. PubMed ID: 9002219
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
